Connection

Michael Zile to Endothelin Receptor Antagonists

Back to Details
This is a "connection" page, showing publications Michael Zile has written about Endothelin Receptor Antagonists.
Michael Zile
Connection Strength
0.459
Endothelin Receptor Antagonists
  1. Randomized, double-blind, placebo-controlled study of sitaxsentan to improve impaired exercise tolerance in patients with heart failure and a preserved ejection fraction. JACC Heart Fail. 2014 Apr; 2(2):123-30.
    View in: PubMed
    Score: 0.459
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.